Bank of Montreal’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History

Bank of Montreal’s Portfolio AST Stock Details AST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-568	Closed	–	–	5127
2018 Q4	$0	Buy	568 +41	+8%	+$43	﹤0.01%	5055
2018 Q3	$1K	Hold	527	–	–	﹤0.01%	4701
2018 Q2	$1K	Hold	527	–	–	﹤0.01%	4685
2018 Q1	$1K	Hold	527	–	–	﹤0.01%	4142
2017 Q4	$1K	Hold	527	–	–	﹤0.01%	4142
2017 Q3	$2K	Hold	527	–	–	﹤0.01%	4069
2017 Q2	$2K	Hold	527	–	–	﹤0.01%	4062
2017 Q1	$2K	Hold	527	–	–	﹤0.01%	3872
2016 Q4	$2K	Hold	527	–	–	﹤0.01%	3937
2016 Q3	$2K	Buy	527 +450	+584%	+$1.46K	﹤0.01%	3903
2016 Q2	$0	Sell	77 -7,896	-99%	-$28.5K	﹤0.01%	4624
2016 Q1	$38K	Hold	7,973	–	–	﹤0.01%	3169
2015 Q4	$32K	Buy	7,973 +2,932	+58%	+$13.5K	﹤0.01%	3219
2015 Q3	$19K	Hold	5,041	–	–	﹤0.01%	3279
2015 Q2	$23K	Sell	5,041 -1,000	-17%	-$9.59K	﹤0.01%	3264
2015 Q1	$40K	Buy	+6,041	New	+$29.9K	﹤0.01%	3016

Bank of Montreal's AST Position: Q1 2019 in Review

Bank of Montreal sold out of Asterias Biotherapeutics Inc. Series A (AST) in Q1 2019, closing a stake of 568 shares.

Bank of Montreal first reported a position in AST in Q1 2015 and held it in 16 quarters. The position peaked at $40K in Q1 2015. 0 funds tracked by Wall St. Rank hold AST as of Q1 2019.

Bank of Montreal reported no remaining Asterias Biotherapeutics Inc. Series A position as of Q1 2019 after selling out during the quarter.
Bank of Montreal sold 568 Asterias Biotherapeutics Inc. Series A shares in Q1 2019.
Bank of Montreal first reported a position in Asterias Biotherapeutics Inc. Series A in Q1 2015 and held it in 16 quarters.
Bank of Montreal's Asterias Biotherapeutics Inc. Series A position peaked at $40K in Q1 2015.
0 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Series A as of Q1 2019.

Based on Bank of Montreal's 13F filing for Q1 2019, filed 26 Apr 2019.